Nanjing Well Pharmaceutical Group Co. Ltd. Class ASSE: 603351

2025 Semi-annual Report

Aug 20, 2025 · Issued by Nanjing Well Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment